Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
24.16
+0.09 (0.37%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Amphastar Pharmaceuticals stock have an average target of 43.5, with a low estimate of 32 and a high estimate of 55. The average target predicts an increase of 80.05% from the current stock price of 24.16.
Analyst Consensus: Hold
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 10, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $36 → $32 | Hold | Maintains | $36 → $32 | +32.45% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $66 → $36 | Buy → Hold | Downgrades | $66 → $36 | +49.01% | Feb 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $55 | Buy | Initiates | $55 | +127.65% | Nov 22, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $71 → $66 | Buy | Maintains | $71 → $66 | +173.18% | Aug 8, 2024 |
Financial Forecast
Revenue This Year
747.74M
from 731.97M
Increased by 2.15%
Revenue Next Year
797.39M
from 747.74M
Increased by 6.64%
EPS This Year
3.20
from 3.06
Increased by 4.44%
EPS Next Year
3.77
from 3.20
Increased by 18.09%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 777.4M | 842.3M | 880.1M | ||
| Avg | 747.7M | 797.4M | 827.3M | ||
| Low | 711.9M | 740.0M | 770.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.2% | 12.6% | 10.4% | ||
| Avg | 2.2% | 6.6% | 3.7% | ||
| Low | -2.7% | -1.0% | -3.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.68 | 4.21 | 4.29 | ||
| Avg | 3.20 | 3.77 | 3.93 | ||
| Low | 2.88 | 3.39 | 3.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.1% | 31.7% | 13.8% | ||
| Avg | 4.4% | 18.1% | 4.2% | ||
| Low | -5.8% | 6.1% | -5.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.